dormakaba Holding AG
No enriched coverage for $DRRKF in the last 7 days.
No SEC Form 4 filings for $DRRKF in the last 30 days.
See all $DRRKF insider activity →dormakaba Group shareholders approved a CHF 0.95 per share dividend, a 3.3% increase from last year, with payments starting 26 Oct 2026. The board was reduced to eight members, and all directors were re-elected for one year, according to the company.
Jefferies upgraded Dormakaba (SIX: DOKA) to 'buy' with a CHF 82 price target, citing margin expansion and U.S. growth. The target implies 34% upside from the Sept. 25 close. The broker expects adjusted EBITDA margins to rise to 18% by fiscal 2028/29, above consensus. Dormakaba reported a record EBITDA margin of 16.1% in fiscal 2025/26, driven by cost savings and pricing gains. The company's restructuring program delivered CHF 235 million in savings, exceeding its target.
dormakaba (DOKA) stock rose 5.2% to CHF 60.8 after reporting a record adjusted EBITDA margin of 16.1% for FY2026. The company proposed acquiring the Mankel family's 47.5% stake for CHF 2.13B and a sale-and-leaseback deal for its HQ exceeding CHF 80M. The board also proposed a 3.3% dividend increase to CHF 0.95 per share.
Recent DRRKF coverage spans earnings, corporate actions and market movers.
dormakaba Group shareholders approved a CHF 0.95 per share dividend, a 3.3% increase from last year, with payments starting 26 Oct 2026. The board was reduced to eight members, and all directors were re-elected for one year, according to the company.
Jefferies upgraded Dormakaba (SIX: DOKA) to 'buy' with a CHF 82 price target, citing margin expansion and U.S. growth. The target implies 34% upside from the Sept. 25 close. The broker expects adjusted EBITDA margins to rise to 18% by fiscal 2028/29, above consensus. Dormakaba reported a record EBITDA margin of 16.1% in fiscal 2025/26, driven by cost savings and pricing gains. The company's restructuring program delivered CHF 235 million in savings, exceeding its target.
dormakaba (DOKA) stock rose 5.2% to CHF 60.8 after reporting a record adjusted EBITDA margin of 16.1% for FY2026. The company proposed acquiring the Mankel family's 47.5% stake for CHF 2.13B and a sale-and-leaseback deal for its HQ exceeding CHF 80M. The board also proposed a 3.3% dividend increase to CHF 0.95 per share.
Dormakaba reported fiscal year net sales of CHF 2.79 billion. The company's financial performance is detailed in the full report. According to Reuters, this data is relevant for investors tracking the firm's revenue trends.
AlphAI scores every news story that mentions DRRKF with an AI model for sentiment and relevance, and aggregates insider trades from dormakaba Holding AG's SEC EDGAR Form 4 filings. Figures refresh continuously.
dormakaba Group shareholders approved a CHF 0.95 per share dividend, a 3.3% increase from last year, with payments starting 26 Oct 2026. The board was reduced to eight members, and all directors were re-elected for one year, according to the company.
1 min readJefferies upgraded Dormakaba (SIX: DOKA) to 'buy' with a CHF 82 price target, citing margin expansion and U.S. growth. The target implies 34% upside from the Sept. 25 close. The broker expects adjusted EBITDA margins to rise to 18% by fiscal 2028/29, above consensus. Dormakaba reported a record EBITDA margin of 16.1% in fiscal 2025/26, driven by cost savings and pricing gains. The company's restructuring program delivered CHF 235 million in savings, exceeding its target.
2 min readdormakaba (DOKA) stock rose 5.2% to CHF 60.8 after reporting a record adjusted EBITDA margin of 16.1% for FY2026. The company proposed acquiring the Mankel family's 47.5% stake for CHF 2.13B and a sale-and-leaseback deal for its HQ exceeding CHF 80M. The board also proposed a 3.3% dividend increase to CHF 0.95 per share.
2 min readDormakaba reported fiscal year net sales of CHF 2.79 billion. The company's financial performance is detailed in the full report. According to Reuters, this data is relevant for investors tracking the firm's revenue trends.
1 min read
